-

News & Events

  • Share Share this page

Public Calendar for week of March 19, 2007

This public calendar is issued by the Food and Drug Administration. It lists meetings held by the FDA policy makers with persons outside the executive branch of the Federal Government.

FDA Official and Title Date and Site Other FDA Participants Non-FDA Participants Subject
Dr. Jesse L. Goodman, MPH, Director, Center for Biologics Evaluation and Research 3/6/07 Bethesda, MD N/A Committe of Ten Thousand Representatives To discuss general topics of interest
Robert Brackett, Director of CFSAN; Janice Oliver, Deputy Center Director for Operations 3/6/07 Harvey Wiley Building, College Park, MD David Acheson, Director, OFDCER; Phil Spiller, OCD; Robert Wagner, OFDCER; Mike Bolger, OFS; Robyn Jones, EOS; Bill Jones, OFS; Don Kraemer, OFS; and Richard Williams, ORPSS Erica Fleisig and Rita Schoeny, EPA/OW; Denise Kechner, EPA/OST; John Wathen and Bill Gross, EPA/OW/DST; Arnold Kuzmack, EPA; and Jeff Bigler, EPA/OW FDA-EPA MOU on Contaminants in Fish: 2007-Update
Dr. Jesse L. Goodman, MPH, Director, Center for Biologics Evaluation and Research 3/8-10/07 Chandler, AZ N/A AdvaMed AdvaMed Annual Meeting
Janice Oliver, Deputy Center Director for Operations 3/13/07 Harvey Wiley Building, College Park, MD Karen Egan, Clarance Murray, Henry Kim, and Mike Bolger, OFS; Robyn Jones, EOS Beth Doyle, Phil Oshida, and David Hardy, EPA FDA-EPA regarding Perchlorate and Total Diet Study
Janet Woodcock, Deputy Commissioner and Chief Medical Officer 3/13/07 Rockville, MD Dr. Rachel Behrman Mara Aspinall and Allison Lawton, Genzyme Meet and Greet
Janet Woodcock, Deputy Commissioner and Chief Medical Officer 3/15/07 Rockville, MD Dr. Rachel Behrman, Dr. Paul Seligman, Ralph Lillie, and Melissa Moncavage Alice Till, Paul Stang, and Jean-Loui Saillot, PhRMA To discuss PhRMA initiative to develop a CME course on adverse event reporting
Andrew C. von Eschenbach, M.D., Commissioner of FDA 3/15/07 Washington, DC Susan Winckler, Mike Landa, Sheldon Bradshaw, Randall Lutter, Bill Frankos, Nega Beru, Barbara Schneeman, Mary Poos, and Wanda Russ NSF International: Kevin Lawlor, Lori Bestervelt, and Stan Hazan; Park and Associates Inc.: Douglas Park; and Sellery Asociates, Inc.: Amy Kimball To discuss advancing third-party programs to meet regulatory mandates.
Margaret Glavin, ACRA, ORA 3/19/07 Jesse Goodman, Deb Autor, Steven Galson, Tim Ulatowski, Daniel Schultz, Diana Kolaitis, David Horowitz, Joe Famulare, Steve Gutman and Mary Malarkey John Landgraf, Joe Nemmers, Michael Beatrice, Cecilia Kimberline and Bob Stewart Update FDA Executive Management on Abbott Laboratories
Murray M. Lumpkin, MD, Deputy Commissioner for International and Special Programs 3/19/07 Basel, Switzerland None University of Basel;ECMP Masters Level Program in Drug Development Students Lecture and workshop regarding an introduction to drug and biologic regulation in the US and areas of convergence with EU systems
Steven Galson, Director, Center for Drug Evaluation and Research 3/13/07 Washington, DC FDA Staff members and officicals Industry Spoke at CERTS PATHs (Partnerships to Advance Therapeutics) Meeting 
    
-
-
-
-
-